Gestational and pregestational diabetes in pregnant women with cystic fibrosis

As cystic fibrosis transmembrane regulator (CFTR) modulator therapies offer greater longevity and improved health quality, women living with cystic fibrosis (CF) are increasingly pursuing pregnancy. Maternal risks for pregnant women with CF largely depend on a woman’s baseline pulmonary and pancreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Oxman, Rachael, Roe, Andrea H., Ullal, Jagdeesh, Putman, Melissa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Special Issue: CF Endocrinology Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693285/
https://www.ncbi.nlm.nih.gov/pubmed/34984172
http://dx.doi.org/10.1016/j.jcte.2021.100289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693285/
https://www.ncbi.nlm.nih.gov/pubmed/34984172
http://dx.doi.org/10.1016/j.jcte.2021.100289

Ejemplares similares